| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30019337 |
| PharmacoGx | BRD-K30019337 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCNA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | TAS2R20 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | NAA25 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | TFAM | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | COL17A1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.07 |
| mRNA | ZNF613 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | NR0B1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BAD | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | KBTBD13 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | KANSL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
